Medifast Q2 revenue falls 43% to $168.6M; net loss $0.75/share, guides Q3 loss

MEDIFAST INC

2024-Q2 EPS reported $0.01 revenue$343,297,000

Revenue $168.6M, down 43.1% YoY; active earning Coaches 33,900 (-36.2%); avg revenue per Coach $4,972 (-10.9%).
GAAP net loss $8.2M ($0.75 loss per diluted share); non-GAAP adjusted net income $10.1M ($0.92 EPS).
Q3 2024 revenue guidance $125M-$145M; diluted loss per share expected $0.05-$0.70.
Cash, equivalents and securities $163.5M; no debt; CEO cites transformation and LifeMD collaboration.
Gross margin improved to 73.2% (non-GAAP 74.8%); SG&A rose to 77.9% of revenue due to fixed-cost deleverage.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.